← Back to headlines
Clearmind Medicine Reports GAAP EPS of -$0.57
Clearmind Medicine Inc. reported a GAAP earnings per share of negative $0.57, reflecting the company's current financial performance metrics.
10 Sept, 20:19 — 10 Sept, 20:19
Sources
Showing 1 of 1 sources
